Pancreatic Cancer Research

ResearcherNippon Medical SchoolNo recent work listed

Eiji Uchida

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110147922. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: 2 papers · 2015: none · 2016: 1 paper

Papers 5

  1. Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. Last author DOI 10.3892/or.2016.4727↗
  2. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases. Co-author DOI 10.1038/onc.2013.392↗
  3. Inhibition of fibroblast growth factor receptor 2 attenuates proliferation and invasion of pancreatic cancer. Co-author DOI 10.1111/cas.12470↗
  4. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation. Co-author DOI 10.1016/j.ajpath.2012.01.020↗
  5. Keratinocyte growth factor induces matrix metalloproteinase-9 expression and correlates with venous invasion in pancreatic cancer. Co-author DOI 10.3892/ijo.2011.1280↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zenya Naito · 5 shared papers, 2012–2016 · strength 0.24
  2. Toshiyuki Ishiwata · 5 shared papers, 2012–2016 · strength 0.24
  3. Yoko Matsuda · 2 shared papers, 2014–2016 · strength 0.12
  4. Junji Ueda · 2 shared papers, 2012–2014 · strength 0.08
  5. Murray Korc · 2 shared papers, 2012–2014 · strength 0.08
  6. Hiroki Sumiyoshi · 1 shared paper, 2016 · strength 0.07
  7. Akira Matsushita · 1 shared paper, 2016 · strength 0.07
  8. Hisashi Yoshimura · 1 shared paper, 2014 · strength 0.05
  9. Kazumitsu Cho · 1 shared paper, 2012 · strength 0.04
  10. Tetsushi Yamamoto · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.